Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Peringkat dalam Saham #1965
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Harga Saham
$177.09
Terakhir disinkronkan: 2026-10-21
Kapitalisasi Pasar
$10.45B
Perubahan (1 hari)
1.76%
Perubahan (1 tahun)
131.10%
Negara
US
Perdagangan Glaukos Corporation (GKOS)

Kategori

Healthcare
Riwayat harga saham Glaukos Corporation (GKOS)
Harga penutupan tertinggi: $166.80 pada 2026-10-01

Harga penutupan terendah: $29.05 pada 2015-06-01
Riwayat harga saham Glaukos Corporation dari 2015 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 16.37%
2025 -22.38%
2024 97.91%
2023 64.84%
2022 1.09%
2021 -38.87%
2020 24.29%
2019 -5.51%
2018 133.10%
2017 -22.73%
2016 38.93%
2015 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$100.56 -21.41%
US
$93.07 -2.95%
IE
$297.13 -23.49%
US
$44.47 -57.18%
US
$46.78 -18.35%
DE